3.10.0.1 html 228 290 1 false 75 0 false 7 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://regenxbio.com/20180930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://regenxbio.com/20180930/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://regenxbio.com/20180930/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss) Sheet http://regenxbio.com/20180930/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss Consolidated Statements of Operations and Comprehensive Income (Loss) Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Cash Flows Sheet http://regenxbio.com/20180930/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100050 - Disclosure - Nature of Business Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureNatureOfBusiness Nature of Business Notes 6 false false R7.htm 100060 - Disclosure - Summary of Significant Accounting Policies Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 100070 - Disclosure - Marketable Securities Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 8 false false R9.htm 100080 - Disclosure - Fair Value of Financial Instruments Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 9 false false R10.htm 100090 - Disclosure - Property and Equipment, Net Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 10 false false R11.htm 100100 - Disclosure - Commitments and Contingencies Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 100110 - Disclosure - License Revenue Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureLicenseRevenue License Revenue Notes 12 false false R13.htm 100120 - Disclosure - Stock-based Compensation Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensation Stock-based Compensation Notes 13 false false R14.htm 100130 - Disclosure - Income Taxes Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 14 false false R15.htm 100140 - Disclosure - Related Party Transactions Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 15 false false R16.htm 100150 - Disclosure - Net Income (Loss) Per Share Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureNetIncomeLossPerShare Net Income (Loss) Per Share Notes 16 false false R17.htm 100160 - Disclosure - Supplemental Disclosures Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSupplementalDisclosures Supplemental Disclosures Notes 17 false false R18.htm 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 100180 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 100190 - Disclosure - Marketable Securities (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureMarketableSecurities 20 false false R21.htm 100200 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureFairValueOfFinancialInstruments 21 false false R22.htm 100210 - Disclosure - Property and Equipment, Net (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosurePropertyAndEquipmentNet 22 false false R23.htm 100220 - Disclosure - Commitments and Contingencies (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingencies 23 false false R24.htm 100230 - Disclosure - License Revenue (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureLicenseRevenueTables License Revenue (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureLicenseRevenue 24 false false R25.htm 100240 - Disclosure - Stock-based Compensation (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensationTables Stock-based Compensation (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensation 25 false false R26.htm 100250 - Disclosure - Net Income (Loss) Per Share (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureNetIncomeLossPerShareTables Net Income (Loss) Per Share (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureNetIncomeLossPerShare 26 false false R27.htm 100260 - Disclosure - Supplemental Disclosures (Tables) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSupplementalDisclosuresTables Supplemental Disclosures (Tables) Tables http://regenxbio.com/20180930/taxonomy/role/DisclosureSupplementalDisclosures 27 false false R28.htm 100270 - Disclosure - Nature of Business - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetail Nature of Business - Additional Information (Detail) Details 28 false false R29.htm 100280 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 29 false false R30.htm 100290 - Disclosure - Summary of Significant Accounting Policies - Schedule of Impact on Consolidated Balance Sheet on Adoption of Topic 606 (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfImpactOnConsolidatedBalanceSheetOnAdoptionOfTopic606Detail Summary of Significant Accounting Policies - Schedule of Impact on Consolidated Balance Sheet on Adoption of Topic 606 (Detail) Details 30 false false R31.htm 100300 - Disclosure - Summary of Significant Accounting Policies - Schedule of Impact on Consolidated Statement of Operations on Adoption of Topic 606 (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfImpactOnConsolidatedStatementOfOperationsOnAdoptionOfTopic606Detail Summary of Significant Accounting Policies - Schedule of Impact on Consolidated Statement of Operations on Adoption of Topic 606 (Detail) Details 31 false false R32.htm 100310 - Disclosure - Summary of Significant Accounting Policies - Schedule of Impact on Consolidated Statement of Cash Flows on Adoption of Topic 606 (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfImpactOnConsolidatedStatementOfCashFlowsOnAdoptionOfTopic606Detail Summary of Significant Accounting Policies - Schedule of Impact on Consolidated Statement of Cash Flows on Adoption of Topic 606 (Detail) Details 32 false false R33.htm 100320 - Disclosure - Summary of Significant Accounting Policies - Summary of Reconciliation of Cash and Cash Equivalents and Restricted Cash (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashDetail Summary of Significant Accounting Policies - Summary of Reconciliation of Cash and Cash Equivalents and Restricted Cash (Detail) Details 33 false false R34.htm 100330 - Disclosure - Marketable Securities - Summary of Company Marketable Securities (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfCompanyMarketableSecuritiesDetail Marketable Securities - Summary of Company Marketable Securities (Detail) Details 34 false false R35.htm 100340 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetail Marketable Securities - Additional Information (Detail) Details 35 false false R36.htm 100350 - Disclosure - Marketable Securities - Summary of Fair Values and Unrealized Losses of Marketable Securities Held by the Company in an Unrealized Loss Position for Less Than 12 months and 12 Months or Greater (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfFairValuesAndUnrealizedLossesOfMarketableSecuritiesHeldByCompanyInUnrealizedLossPositionForLessThan12MonthsAnd12MonthsOrGreaterDetail Marketable Securities - Summary of Fair Values and Unrealized Losses of Marketable Securities Held by the Company in an Unrealized Loss Position for Less Than 12 months and 12 Months or Greater (Detail) Details 36 false false R37.htm 100360 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value of Cash Equivalents and Marketable Securities (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfFairValueOfCashEquivalentsAndMarketableSecuritiesDetail Fair Value of Financial Instruments - Schedule of Fair Value of Cash Equivalents and Marketable Securities (Detail) Details 37 false false R38.htm 100370 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail Fair Value of Financial Instruments - Additional Information (Detail) Details 38 false false R39.htm 100380 - Disclosure - Property and Equipment Net - Schedule of Property and Equipment (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetail Property and Equipment Net - Schedule of Property and Equipment (Detail) Details 39 false false R40.htm 100390 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 40 false false R41.htm 100400 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetail Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Detail) Details 41 false false R42.htm 100410 - Disclosure - Commitments and Contingencies - Summary of Expenses Incurred by Company (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfExpensesIncurredByCompanyDetail Commitments and Contingencies - Summary of Expenses Incurred by Company (Detail) Details 42 false false R43.htm 100420 - Disclosure - License Revenue - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureLicenseRevenueAdditionalInformationDetail License Revenue - Additional Information (Detail) Details 43 false false R44.htm 100430 - Disclosure - License Revenue - Summary of Changes in Balances of Receivables, Contract Assets and Contract Liabilities (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureLicenseRevenueSummaryOfChangesInBalancesOfReceivablesContractAssetsAndContractLiabilitiesDetail License Revenue - Summary of Changes in Balances of Receivables, Contract Assets and Contract Liabilities (Detail) Details 44 false false R45.htm 100440 - Disclosure - License Revenue - Additional Information (Detail1) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureLicenseRevenueAdditionalInformationDetail1 License Revenue - Additional Information (Detail1) Details 45 false false R46.htm 100450 - Disclosure - Stock-based Compensation - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-based Compensation - Additional Information (Detail) Details 46 false false R47.htm 100460 - Disclosure - Stock-based Compensation - Stock-Based Compensation Expense by Award Type (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseByAwardTypeDetail Stock-based Compensation - Stock-Based Compensation Expense by Award Type (Detail) Details 47 false false R48.htm 100470 - Disclosure - Stock-based Compensation - Stock-Based Compensation Expense (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetail Stock-based Compensation - Stock-Based Compensation Expense (Detail) Details 48 false false R49.htm 100480 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetail Stock-based Compensation - Summary of Stock Option Activity (Detail) Details 49 false false R50.htm 100490 - Disclosure - Stock-based Compensation - Summary of Unvested RSUs Activity Under 2015 Plan (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureStockBasedCompensationSummaryOfUnvestedRsusActivityUnder2015PlanDetail Stock-based Compensation - Summary of Unvested RSUs Activity Under 2015 Plan (Detail) Details 50 false false R51.htm 100500 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 51 false false R52.htm 100510 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 52 false false R53.htm 100520 - Disclosure - Net Income (Loss) Per Share - Computations of Basic and Diluted Net Income (Loss) Per Share (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureNetIncomeLossPerShareComputationsOfBasicAndDilutedNetIncomeLossPerShareDetail Net Income (Loss) Per Share - Computations of Basic and Diluted Net Income (Loss) Per Share (Detail) Details http://regenxbio.com/20180930/taxonomy/role/DisclosureNetIncomeLossPerShareTables 53 false false R54.htm 100530 - Disclosure - Net Income (Loss) Per Share - Schedules for Computation of Diluted Weighted-Average Shares Outstanding (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureNetIncomeLossPerShareSchedulesForComputationOfDilutedWeightedAverageSharesOutstandingDetail Net Income (Loss) Per Share - Schedules for Computation of Diluted Weighted-Average Shares Outstanding (Detail) Details http://regenxbio.com/20180930/taxonomy/role/DisclosureNetIncomeLossPerShareTables 54 false false R55.htm 100540 - Disclosure - Supplemental Disclosures - Schedules of Accrued Expenses and Other Current Liabilities (Detail) Sheet http://regenxbio.com/20180930/taxonomy/role/DisclosureSupplementalDisclosuresSchedulesOfAccruedExpensesAndOtherCurrentLiabilitiesDetail Supplemental Disclosures - Schedules of Accrued Expenses and Other Current Liabilities (Detail) Details 55 false false All Reports Book All Reports rgnx-20180930.xml rgnx-20180930.xsd rgnx-20180930_cal.xml rgnx-20180930_def.xml rgnx-20180930_lab.xml rgnx-20180930_pre.xml http://xbrl.sec.gov/stpr/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 true true